Clinical Scorecard: Therapeutic Approaches Targeting Gut Microbiota in Elderly-Onset Rheumatoid Arthritis: Insights from the Gut-Joint Connection

At a Glance

Key Highlights

• EORA presents distinct clinical challenges compared to younger-onset RA.
• The gut-joint axis plays a significant role in the pathogenesis of EORA.
• Therapeutic strategies include dietary modifications, nutraceuticals, and fecal microbiota transplantation.
• Immunosenescence and inflammaging are key factors in EORA pathology.
• Increased levels of inflammatory markers are associated with aging and RA progression.
• Monitoring inflammatory markers is crucial for managing EORA.

Guideline-Based Recommendations

Diagnosis

• Consider distinct clinical characteristics and serological profiles in EORA.

Management

• Explore microbiota-targeted interventions for optimizing clinical management.
• Implement specific dietary modifications based on current evidence.

Monitoring & Follow-up

• Monitor levels of inflammatory markers such as CRP, IL-6, and TNF-α.

Risks

• Increased comorbidity burden and mortality in EORA patients.

Patient & Prescribing Data

Elderly patients with rheumatoid arthritis, particularly those over 60 years.

Microbiota-targeted interventions may improve disease management.

Clinical Best Practices

• Assess the interplay between immunosenescence and gut microbiota in EORA patients.
• Implement dietary modifications as part of a comprehensive treatment plan.
• Consider fecal microbiota transplantation as a potential intervention.

Related Resources & Content

• Cezar et al. (2023)
• Accardi et al. (2023)